Influence

November 2024

• 11/22 - Prevalence of Unrecognized Cognitive Impairment in Federally Qualified Health Centers

• 11/18 - Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

• 11/13 - AMIA honors Regenstrief researcher with leadership award

• 11/11 - Regenstrief researchers share international conference stage

October 2024

• 10/25 - Regenstrief president participates in media panel with national experts

• 10/25 - Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial

• 10/24 - Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement

• 10/1 - Regenstrief Institute researcher highlights qualitative outcomes from breast cancer study at international conference

September 2024

• 9/25 - Picking Up PrEP-Role of Clinician Specialty

• 9/18 - NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024

• 9/12 - Experiences With Unionization Among General Surgery Resident Physicians, Faculty, and Staff

• 9/4 - Telehealth Mindfulness-Based Interventions for Chronic Pain: The LAMP Randomized Clinical Trial

August 2024

• 8/13 - Neighborhood Resources Associated With Psychological Trajectories and Neural Reactivity to Reward After Trauma

• 8/7 - Impact of interhospital transfer on patients with Alzheimer’s disease and other related dementias

July 2024

• 7/24 - Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years – VISION Network, United States, July 2022-June 2023

June 2024

• 6/25 - Risk factors for dementia in older intensive care unit (ICU) survivors

• 6/5 - 1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma

May 2024

• 5/29 - Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial

• 5/14 - Study provides blueprint for hybrid-virtual home visit model to support patients who do not live close to a hospital

• 5/7 - Effect of modernized collaborative care for depression on depressive symptoms and cardiovascular disease risk biomarkers: eIMPACT randomized controlled trial

• 5/1 - Mobile Critical Care Recovery Program for Survivors of Acute Respiratory Failure: A Randomized Clinical Trial

April 2024

• 4/23 - Call for Papers on Artificial Intelligence Applied to Pediatric Care

• 4/2 - Primary Care Interventions to Prevent Child Maltreatment: US Preventive Services Task Force Recommendation Statement

March 2024

• 3/26 - An Integrative Review of the State of POLST Science: What Do We Know and Where Do We Go?

• 3/20 - HIV, Social Networks, and Loneliness among Older Adults in Uganda

• 3/14 - Factors Affecting Treatment Selection Among Patients With Hidradenitis Suppurativa

• 3/5 - Institutional Variability in Respiratory Support use for Pediatric Critical Asthma: A Multicenter Retrospective Study 

• 3/1 - The Impact of Patient Race, Patient Socioeconomic Status, and Cognitive Load of Physician Residents and Fellows on Chronic Pain Care Decisions

February 2024

• 2/26 - Effect of a Novel Multicomponent Intervention to Improve Patient Access to Kidney Transplant and Living Kidney Donation: The EnAKT LKD Cluster Randomized Clinical Trial 

September 2023

• 9/1 - Regenstrief researcher named chair of quality committee of one of nation’s largest medical professional organizations

May 2023

• 5/15 - Regenstrief researcher featured speaker at UsAgainstAlzheimer’s event in Washington, DC

April 2023

• 4/28 - Study shows improvement for female population typically with low cancer screening rates

October 2022

• 10/25 - Texas expert discusses mental health struggles for patients in Lone Star State as well as Indiana 

August 2022

• 8/31 - COOPERATE: Regenstrief and VA Research Scientists addressing health disparity at the patient level

• 8/23 - Regenstrief research scientist 1 of 33 NIA small business mentors

May 2022

• 5/17 - Regenstrief expert visits Kenya: Helps extend impact of AMPATH, sees results of Regenstrief long-term mentoring and success in resource-constrained environments

• 5/3 - Regenstrief researcher participates in expert panel discussion on life sciences and business climate

April 2022

• 4/18 - Research from Regenstrief gastroenterologist makes impact; article recognized by professional journal as 1 of most widely cited for 2020-2021

• 4/15 - Pandemic leads to maturation of real-time science: Regenstrief researchers lead the way in real-world data analysis

• 4/7 - Regenstrief expert helps identify implementation strategies to improve cirrhosis care

March 2022

• 3/31 - Regenstrief researcher will be part of life sciences expert panel

• 3/21 - Revolutionizing research through pragmatic trials

February 2022

• 2/16 - ‘Memory loss is not normal aging’ — Regenstrief scientist highlights challenges of living with dementia

January 2022

• 1/28 - Regenstrief expert applies novel analysis method in study measuring program implementation success

December 2021

• 12/29 - Experts provide context to data as Omicron surges

• 12/20 - Data from the Regenstrief COVID-19 dashboard informs decisions and addresses health disparities

• 12/10 - Computerized tools provide golden opportunities for clinical decision support in team care

• 12/2 - First study to qualitatively describe primary care provider experience with chronic cough

November 2021

• 11/4 - Regenstrief data experts contribute to NEJM, CDC COVID-19 papers

• 11/1 - Regenstrief scientist highlights benefits of gene-specific approaches to colon cancer surveillance